Hemizygosity Enables a Mutational Transition Governing Fungal Virulence and Commensalism
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Summary Candida albicans is a commensal fungus of human gastrointestinal and reproductive tracts, but also causes life-threatening systemic infections. The balance between colonization and pathogenesis is associated with phenotypic plasticity, with alternative cell states producing different outcomes in a mammalian host. Here, we reveal that gene dosage of a master transcription factor regulates cell differentiation in diploid C. albicans cells, as EFG1 hemizygous cells undergo a phenotypic transition inaccessible to ‘wildtype’ cells with two functional EFG1 alleles. Notably, clinical isolates are often EFG1 hemizygous and thus licensed to undergo this transition. Phenotypic change corresponds to high-frequency loss of the functional EFG1 allele via de novo mutation or gene conversion events. This phenomenon also occurs during passaging in the gastrointestinal tract with the resulting cell type being hypercompetitive for commensal and systemic infections. A ‘two-hit’ genetic model therefore underlies a key phenotypic transition in C. albicans that enables adaptation to host niches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Nonfilamentous C. albicans Mutants Are Avirulent
Lo, H.-J., Köhler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A., & Fink, G. R. (1997) · Cell · doi:10.1016/s0092-8674(00)80358-x · Cited by 1,809 · cited 3×
“In a systemic infection, white cells were more virulent than gray cells, consistent with the critical role of EFG1 in pathogenesis (Lo et al., 1997; Park et al., 2005).”
BackgroundResultGrowth of Candida albicans hyphae
Sudbery, P. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2636 · Cited by 1,110 · cited 2×
“This fungus can grow as single-celled yeast or as filamentous cells (Sudbery, 2011) and can also adopt alternative yeast-like cell types; these are defined by distinct cell and colony morphologies and show striking differences in colonization and pathogenesis (Noble et al., 2017).”
BackgroundNoble, S. M., French, S., Kohn, L. A., Chen, V., & Johnson, A. D. (2010) · Nature Genetics · doi:10.1038/ng.605 · Cited by 678 · cited 1×
“White cells colonize the gastrointestinal tract (GI) and are virulent in disseminated infections (Noble et al., 2010; Pande et al., 2013), whereas gray cells are avirulent in the systemic model yet can colonize the mouse tongue ex vivo (Tao et al.”
BackgroundSaville, S. P., Lazzell, A. L., Monteagudo, C., & Lopez-Ribot, J. L. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.5.1053-1060.2003 · Cited by 655 · cited 1×
“This extends prior observations in which kidney fungal burdens did not correlate with virulence in strains with a decreased ability to undergo filamentation (Bendel et al., 2003; Felk et al., 2002; Saville et al., 2003).”
BackgroundNoble, S. M., & Johnson, A. D. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.2.298-309.2005 · Cited by 592 · cited 4×
“PCR was also used to amplify HIS1 or LEU2 markers from plasmids pSN52 and pSN40, respectively, as described (Noble and Johnson, 2005).”
MethodInfluentialSkrzypek, M. S., Binkley, J., Binkley, G., Miyasato, S. R., Simison, M., & Sherlock, G. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw924 · Cited by 455
Repeat instability as the basis for human diseases and as a potential target for therapy
López Castel, A., Cleary, J. D., & Pearson, C. E. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2854 · Cited by 429
Coste, A., Turner, V., Ischer, F., Morschhäuser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., & Sanglard, D. (2006) · Genetics · doi:10.1534/genetics.105.054767 · Cited by 385
The evolution of drug resistance in clinical isolates of Candida albicans.
Ford, C. B., Funt, J. M., Abbey, D., Issi, L., Guiducci, C., Martinez, D. A., Delorey, T., Li, B. Y., White, T. C., Cuomo, C., et al. (2015) · eLife · doi:10.7554/elife.00662 · Cited by 348 · cited 4×
“albicans genome sequences—Whole genome sequences of the 21 clinical isolates (NCBI BioProject ID: PRJNA193498) and 43 clinical isolates from the OPC patients (NCBI BioProject ID: PRJNA257929) were obtained from previous studies (Ford et al., 2015; Hirakawa et al., 2015) and aligned to the SC5314 reference genome v21 (…”
BackgroundMethodInfluentialGenetic and phenotypic intra-species variation in Candida albicans
Hirakawa, M. P., Martinez, D. A., Sakthikumar, S., Anderson, M. Z., Berlin, A., Gujja, S., Zeng, Q., Zisson, E., Wang, J. M., Greenberg, J. M., et al. (2015) · Genome Research · doi:10.1101/gr.174623.114 · Cited by 320 · cited 5×
“albicans genome sequences—Whole genome sequences of the 21 clinical isolates (NCBI BioProject ID: PRJNA193498) and 43 clinical isolates from the OPC patients (NCBI BioProject ID: PRJNA257929) were obtained from previous studies (Ford et al., 2015; Hirakawa et al., 2015) and aligned to the SC5314 reference genome v21 (…”
BackgroundMethodResultInfluentialSelf-citationPande, K., Chen, C., & Noble, S. M. (2013) · Nature Genetics · doi:10.1038/ng.2710 · Cited by 306 · cited 6×
“White cells colonize the gastrointestinal tract (GI) and are virulent in disseminated infections (Noble et al., 2010; Pande et al., 2013), whereas gray cells are avirulent in the systemic model yet can colonize the mouse tongue ex vivo (Tao et al.”
BackgroundMethodResultInfluentialCandida albicans forms biofilms on the vaginal mucosa
Harriott, M. M., Lilly, E. A., Rodriguez, T. E., Fidel, P. L., & Noverr, M. C. (2010) · Microbiology · doi:10.1099/mic.0.039354-0 · Cited by 301 · cited 1×
“As evidenced here, the efg1 null state also provides a fitness advantage in several infection types, yet previous work has established that EFG1 function is critical for infection of other host niches (Harriott et al., 2010; Stoldt et al., 1997; Yano et al., 2016).”
BackgroundInterlocking Transcriptional Feedback Loops Control White-Opaque Switching in Candida albicans
Zordan, R. E., Miller, M. G., Galgoczy, D. J., Tuch, B. B., & Johnson, A. D. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050256 · Cited by 292 · cited 3×
“The frequency of white-to-INT switching was similar to that for white-to-opaque switching under standard culture conditions (Slutsky et al., 1987; Zordan et al., 2007).”
BackgroundWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1488 · Cited by 292
Metabolic specialization associated with phenotypic switching in Candida albicans
Lan, C.-Y., Newport, G., Murillo, L. A., Jones, T., Scherer, S., Davis, R. W., & Agabian, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232566499 · Cited by 275 · cited 1×
“This is consistent with EFG1 regulating metabolic gene expression (Doedt et al., 2004; Lan et al., 2002; Pierce et al., 2013).”
ResultStress Alters Rates and Types of Loss of Heterozygosity in Candida albicans
Forche, A., Abbey, D., Pisithkul, T., Weinzierl, M. A., Ringstrom, T., Bruck, D., Petersen, K., & Berman, J. (2011) · mBio · doi:10.1128/mbio.00129-11 · Cited by 234
Park, H., Myers, C. L., Sheppard, D. C., Phan, Q. T., Sanchez, A. A., E. Edwards, J., & Filler, S. G. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00476.x · Cited by 207 · cited 1×
“In a systemic infection, white cells were more virulent than gray cells, consistent with the critical role of EFG1 in pathogenesis (Lo et al., 1997; Park et al., 2005).”
BackgroundGene flow contributes to diversification of the major fungal pathogen Candida albicans
Ropars, J., Maufrais, C., Diogo, D., Marcet-Houben, M., Perin, A., Sertour, N., Mosca, K., Permal, E., Laval, G., Bouchier, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04787-4 · Cited by 197
Global analysis of mutations driving microevolution of a heterozygous diploid fungal pathogen
Ene, I. V., Farrer, R. A., Hirakawa, M. P., Agwamba, K., Cuomo, C. A., & Bennett, R. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806002115 · Cited by 155 · cited 1×
“albicans genome (Ene et al., 2018; Forche et al., 2011) and suggests that EFG1 may represent a hotspot for gene conversion and/or mutational events.”
BackgroundSelf-citationStructure of the transcriptional network controlling white‐opaque switching in C andida albicans
Hernday, A. D., Lohse, M. B., Fordyce, P. M., Nobile, C. J., DeRisi, J. L., & Johnson, A. D. (2013) · Molecular Microbiology · doi:10.1111/mmi.12329 · Cited by 131 · cited 1×
“This epigenetic switch is regulated by a transcription factor (TF) circuit that includes Efg1, which promotes white cell formation, and Wor1, which promotes opaque cell formation (Hernday et al., 2013; Huang et al., 2006; Sonneborn et al., 1999; Srikantha et al., 2006; Zordan et al., 2006; Zordan et al., 2007).”
BackgroundThe Genetics of Neisseria Species
Rotman, E., & Seifert, H. S. (2014) · Annual Review of Genetics · doi:10.1146/annurev-genet-120213-092007 · Cited by 122
Bennett, R. J., Forche, A., & Berman, J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019604 · Cited by 118 · cited 2×
“The mechanisms that promote adaptation in fungal pathogens include epigenetic switching, aneuploid formation, mutator states, and sexual/parasexual reproduction (Bennett et al., 2014; Calo et al., 2013; Heitman et al., 2014; Kwon-Chung and Chang, 2012; Noble et al., 2017).”
BackgroundSelf-citationThe role of nutrient regulation and the Gpa2 protein in the mating pheromone response of C. albicans
Bennett, R. J., & Johnson, A. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05367.x · Cited by 74 · cited 1×
“Products were combined by fusion PCR using oligos 2251/2254 and the HIS1-containing product transformed into SC5314-derived strains SN87 (Noble and Johnson, 2005) and RBY1132 (Bennett and Johnson, 2006) to generate efg1Δ/EFG1 strains in MTLa/α and MTLa/a backgrounds (CAY6970, 6973, 6976 and 7064).”
MethodSelf-citation
Cited by
d'Enfert, C., Kaune, A.-K., Alaban, L.-R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 347
Immune regulation by fungal strain diversity in inflammatory bowel disease
Li, X. V., Leonardi, I., Putzel, G. G., Semon, A., Fiers, W. D., Kusakabe, T., Lin, W.-Y., Gao, I. H., Doron, I., Gutierrez-Guerrero, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04502-w · Cited by 302
Gut Mycobiota in Immunity and Inflammatory Disease
Li, X. V., Leonardi, I., & Iliev, I. D. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.023 · Cited by 246
Candida albicans and Candida glabrata : global priority pathogens
Katsipoulaki, M., Stappers, M. H. T., Malavia-Jones, D., Brunke, S., Hube, B., & Gow, N. A. R. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00021-23 · Cited by 180
Candida albicans Interactions with Mucosal Surfaces during Health and Disease
Nikou, S.-A., Kichik, N., Brown, R., Ponde, N., Ho, J., Naglik, J., & Richardson, J. (2019) · Pathogens · doi:10.3390/pathogens8020053 · Cited by 103
Metadata
- Authors
- Liang, S.-H., Anderson, M. Z., Hirakawa, M. P., Wang, J. M., Frazer, C., Alaalm, L. M., Thomson, G. J., Ene, I. V., & Bennett, R. J.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 25
- Issue
- 3
- Pages
- 418-431.e6
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2916088628
- Cited by
- 89
- References
- 26
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.